Zdrowie i gospodarka · 01/11/2017
FDA Classifies BCR-ABL Quantitation Test into Class II with Special Controls
The FDA has classified the BCR-ABL quantitation test into Class II with special controls, aiming to ensure safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.
Source: Federal Register — Food and Drug AdministrationOpen original release →